2017 in Quotes

Gender discrimination, Brexit, and climate change are among the issues that have received considerable attention from the scientific community this year.

Dec 28, 2017
Catherine Offord


They have a patent on green tennis balls. We [likely] will have a patent on all tennis balls. . . . I don’t think it really makes sense.

—University of California, Berkeley, structural biologist Jennifer Doudna speaking to reporters after the US Patent and Trademark Office’s Trial and Appeal Board ruled in favor of the Broad Institute in an ongoing legal battle over patents for CRISPR genome-editing technology (February 15)


Everything he did, he was ahead of everybody in so many ways. He was a genius of a very special type. Not only because he had this incredible imagination and brain, but he had incredible tenacity and courage.

Vitek Tracz, publisher of Faculty of 1000 and former co-owner of The Scientist, on the passing of Eugene Garfield, the scientometrics pioneer who launched The Scientist in 1986 (February 27)


I think that measuring with precision human activity on the climate is something very challenging to do, and there’s tremendous disagreement about the degree of impact, so no, I would not agree that it’s a primary contributor to the global warming that we see.

—US Environmental Protection Agency Administrator Scott Pruitt, on the CNBC program Squawk Box shortly after his confirmation (March 9)


What is worse, the Administration and Board of Trustees . . . have known about this discrimination, yet done absolutely nothing to stop it or right the wrongs perpetrated against its equally talented and decorated female Full Professors.

—Molecular biologist Beverly Emerson of the Salk Institute for Biological Studies in a lawsuit brought against Salk for gender discrimination, following similar suits from two other female full professors (July 18)


I’m simply stating that the distribution of preferences and abilities of men and women differ in part due to biological causes and that these differences may explain why we don’t see equal representation of women in tech and leadership.

—A memo, penned by software engineer James Damore, decrying what he calls “arbitrary social engineering” aimed at increasing workplace diversity at Google, which fired him after the document circulated first inside then outside the company, according to Gizmodo (August 5)


I firmly believe that scientists should have the intellectual freedom to tackle the most pressing issues of the day, regardless of the political landscape.

—Ecologist Jennifer Bowen of Northeastern University’s Marine Science Center, writing in an email to The Washington Post after receiving instructions to remove the phrase “climate change” from a federal grant proposal (August 28)


You can’t have a meeting where people get together to decide [if] there should be funding in a particular aspect of biology when it’s not clear that the U.K. will be participating.

—University of Cambridge plant biologist Alison Smith, speaking to The Scientist about the effect of uncertainty following Brexit on UK researchers’ capacity to help direct international research initiatives (September 12)


He’s back to school, he’s exercising, he’s started to play soccer . . . it’s quite amazing.

—Regenerative medicine specialist Michele De Luca of the University of Modena and Reggio Emilia, describing to The Scientist progress in a young Syrian boy who received a transgenic
skin transplant
over most of his body (November 8)


Studies like this [are] extremely crucial. Unfortunately things didn’t work out. . . . We will do our best to do better next time.

Suresh Garimella, executive vice president for research and partnerships at Purdue University, after the closure of the Camp DASH nutritional study following allegations of sexual assault among its adolescent participants, according to the Journal & Courier (November 28)


I’m truly honored to receive this award, humbled to be in such distinguished company and tremendously gratified that the study of plants, which is essential to developing everything from better agricultural practices to mitigating global warming, has been put in the spotlight with this award.

Joanne Chory, a plant biologist at the Salk Institute for Biological Studies, in a press release on receiving one of this year’s Breakthrough Prizes for her work on the mechanisms of plant responses to shade (December 3)

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb


Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!